These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26911307)

  • 1. Emerging nanomedicine applications and manufacturing: progress and challenges.
    Sartain F; Greco F; Hill K; Rannard S; Owen A
    Nanomedicine (Lond); 2016 Mar; 11(6):577-80. PubMed ID: 26911307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the translation in Europe of nanomedicines (a.k.a. drug delivery) from academia to industry.
    Eaton MA
    J Control Release; 2012 Dec; 164(3):370-1. PubMed ID: 22721816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.
    Mu Q; Yu J; McConnachie LA; Kraft JC; Gao Y; Gulati GK; Ho RJY
    J Drug Target; 2018; 26(5-6):435-447. PubMed ID: 29285948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine at the crossroads - A quick guide for IVIVC.
    Mast MP; Modh H; Champanhac C; Wang JW; Storm G; Krämer J; Mailänder V; Pastorin G; Wacker MG
    Adv Drug Deliv Rev; 2021 Dec; 179():113829. PubMed ID: 34174332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle Strategies for Biomedical Applications: Reviews from the University of Southern California Viterbi School of Engineering.
    Chung EJ
    SLAS Technol; 2019 Apr; 24(2):135-136. PubMed ID: 30890058
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation.
    Taha MS; Padmakumar S; Singh A; Amiji MM
    Drug Deliv Transl Res; 2020 Jun; 10(3):766-790. PubMed ID: 32170656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening.
    Castro F; Leite Pereira C; Helena Macedo M; Almeida A; José Silveira M; Dias S; Patrícia Cardoso A; José Oliveira M; Sarmento B
    Adv Drug Deliv Rev; 2021 Aug; 175():113824. PubMed ID: 34090966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology: Deliver on a promise.
    Wright J
    Nature; 2014 May; 509(7502):S58-9. PubMed ID: 24870822
    [No Abstract]   [Full Text] [Related]  

  • 10. Piezoelectric nanomaterials: latest applications in biomedicine and challenges in clinical translation.
    Marino A; Bargero A; Ciofani G
    Nanomedicine (Lond); 2024; 19(12):1029-1034. PubMed ID: 38573156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational nanomedicine: status assessment and opportunities.
    Murday JS; Siegel RW; Stein J; Wright JF
    Nanomedicine; 2009 Sep; 5(3):251-73. PubMed ID: 19540359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo.
    Pearce AK; Fuchs AV; Fletcher NL; Thurecht KJ
    Pharm Res; 2016 Oct; 33(10):2388-99. PubMed ID: 27225496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines for kidney diseases.
    Williams RM; Jaimes EA; Heller DA
    Kidney Int; 2016 Oct; 90(4):740-5. PubMed ID: 27292222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues affecting nanomedicines on the way from the bench to the market.
    Longo JPF; Mussi S; Azevedo RB; Muehlmann LA
    J Mater Chem B; 2020 Dec; 8(47):10681-10685. PubMed ID: 33155000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-drug conjugates: origins, progress to date and future directions.
    Kopeček J
    Adv Drug Deliv Rev; 2013 Jan; 65(1):49-59. PubMed ID: 23123294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Particle Size in Translational Research of Nanomedicines for Successful Drug Delivery: Discrepancies and Inadequacies.
    Chan HW; Chow S; Zhang X; Kwok PCL; Chow SF
    J Pharm Sci; 2023 Sep; 112(9):2371-2384. PubMed ID: 37453526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coming era of nanomedicine.
    Allhoff F
    Am J Bioeth; 2009 Oct; 9(10):3-11. PubMed ID: 19998074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
    Raza F; Zafar H; You X; Khan A; Wu J; Ge L
    J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational Multi-Disciplinary Approach for the Drug and Gene Delivery Systems for Cancer Treatment.
    Nayak R; Meerovich I; Dash AK
    AAPS PharmSciTech; 2019 Apr; 20(4):160. PubMed ID: 30968269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.